Literature DB >> 9231758

Lack of effect of thyroid hormone on late fetal rat brain development.

H L Schwartz1, M E Ross, J H Oppenheimer.   

Abstract

Studies were undertaken to test whether alterations in fetal brain thyroid hormone levels during the final week of gestation can prematurely induce gene expression in brain or affect cerebellar morphogenesis. Pregnant dams were treated either by administration of 0.025% methimazole (MMI) in the drinking water from day 14 post conception (PC14) or administration of 2.5 mg T4/100 g BW on PC15. On PC21, treatment with MMI resulted in a 53% fall in fetal brain T3 levels and excess T4 resulted in a 2- to 3-fold increase to concentrations observed in adult brains. Neither excess nor reduced levels of T3 caused alterations in the expression of the myelin basic protein, Pcp-2 or calmodulin kinase IV genes. Cerebella of control brains showed early evidence of foliation and the presence of a several cell thick Purkinje cell layer and an external granule layer. No treatment induced effects were evident. Thus, at the late fetal stage in the rat, the developing brain appears to be unresponsive to thyroid hormone despite the presence of thyroid hormone receptors. We infer the presence of as yet unidentified factors that suppress precocious response to thyroid hormone or the absence of cofactors essential for such a response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231758     DOI: 10.1210/endo.138.8.5353

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase.

Authors:  V A Galton; E Martinez; A Hernandez; E A St Germain; J M Bates; D L St Germain
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 2.  An overview of nuclear receptor coregulators involved in cerebellar development.

Authors:  Eijun Nishihara
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 3.  Thyroid hormone and cerebellar development.

Authors:  Grant W Anderson
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

4.  Adult onset of type 3 deiodinase deficiency in mice alters brain gene expression and increases locomotor activity.

Authors:  J Patrizia Stohn; M Elena Martinez; Donald L St Germain; Arturo Hernandez
Journal:  Psychoneuroendocrinology       Date:  2019-09-18       Impact factor: 4.905

5.  DNA Methylation of the EphA5 Promoter Is Associated with Rat Congenital Hypothyroidism.

Authors:  Youjia Wu; Honghua Song; Baolan Sun; Meiyu Xu; Jinlong Shi
Journal:  J Mol Neurosci       Date:  2015-06-25       Impact factor: 3.444

6.  Thyroid hormone regulates reelin and dab1 expression during brain development.

Authors:  M Alvarez-Dolado; M Ruiz; J A Del Río; S Alcántara; F Burgaya; M Sheldon; K Nakajima; J Bernal; B W Howell; T Curran; E Soriano; A Muñoz
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

Review 7.  Thyroid hormone actions on neural cells.

Authors:  Sandra König; Vivaldo Moura Neto
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

Review 8.  Current perspectives on the role of thyroid hormone in growth and development of cerebellum.

Authors:  Noriyuki Koibuchi; Hisaka Jingu; Toshiharu Iwasaki; William W Chin
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

9.  Analysis of EphA5 receptor in the developing rat brain: an in vivo study in congenital hypothyroidism model.

Authors:  You-jia Wu; Mei-yu Xu; Lei Wang; Bao-lan Sun; Gui-xiong Gu
Journal:  Eur J Pediatr       Date:  2013-05-01       Impact factor: 3.183

10.  PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors.

Authors:  A M Canudas; V Di Giorgi-Gerevini; L Iacovelli; G Nano; M D'Onofrio; A Arcella; F Giangaspero; C Busceti; L Ricci-Vitiani; G Battaglia; F Nicoletti; D Melchiorri
Journal:  J Neurosci       Date:  2004-11-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.